+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Humulone

BP1607
26472-41-3
98%
普瑞法
Humulus lupulus Linn.
Humulone, a bone resorption inhibitor, induces apoptosis may via its antioxidative activity in the premyocytic leukemia cell line HL-60 between 1 and 100 micrograms/ml. Humulone is also a potent angiogenic inhibitor, can inhibit cyclooxygenase-2 and may be a novel powerful tool for the therapy of various angiogenic diseases involving solid tumor growth and metastasis. Humulone also has antioxidant, antispasmodic, antiviral and antibacterial activities. Humulone is an optically active cyclic ketone consisting of 3,5,6-trihydroxycyclohexa-2,4-dien-1-one bearing two 3-methylbut-2-en-1-yl substituents at positions 4 and 6 as well as a 3-methylbutanoyl group at the 2-position. It has a role as an antioxidant, a metabolite, an antibacterial drug and a cyclooxygenase 2 inhibitor. It is a tertiary alpha-hydroxy ketone, a triol, a cyclic ketone, a diketone and an aromatic ketone.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1607-5mg 5mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

BCL2 STAT3 HIF1A RELA TNF MMP9 PTGS2 CASP3 VEGFA KDR
DRD2 GABRA1 GABRG2

Product drug property prediction parameters

  • 86.1800

  • 4.1500

  • Low

  • No

  • No

  • No

  • Unknown

  • No

  • Unknown